ASAM updates

The American Society of Addiction Medicine collated recent developments on Psychosocial interventions while on meds, extra-medical use of medications, collaborative care for risky opioid use, AI-enabling urine drug testing interpretation, and opioid-associated hippocampal injury. “From the rescheduling of cannabis (The Hill) and the surging prevalence of nicotine pouches like Zyn (NBC), to the structural setbacks face-to-face with the alcohol industry (STAT), our field is moving at a breakneck pace.”